USANA HEALTH SCIENCES INC (USNA)

Medicinal Chemicals & Botanical Products

Latest Price

$14.90

TTM P/E

Normalized P/E

6.66

Div Yield

Book Value

28.54

P/B Ratio

0.52

Valuation metrics

EPS: $0.58

Book value / share: $29.16

Formula: √(22.5 × EPS × BVPS)

Graham Number

$19.51

+31% upside

Norm. op. income: $108M (median of 5yr)

Tax rate: 36%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$46.25

+210% upside

Base FCF: $94M (median of recent 5yr)

Growth: -15%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$30.45

+104% upside

EPS: $0.58

Target P/E: 7×

Formula: EPS × P/E

P/E Fair Value

$4.06

73% downside

62.3% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	1.55M	$33.0M	8.42%	+363.8K	2026-06-30
PZENA INVESTMENT MANAGEMENT LLC	1.21M	$25.0M	6.53%	+96.7K	2026-06-30
RENAISSANCE TECHNOLOGIES LLC	958.5K	$20.0M	5.19%	-59.1K	2026-06-30
DIMENSIONAL FUND ADVISORS LP	837.4K	$17.0M	4.54%	+3.2K	2026-06-30
Nantahala Capital Management, LLC	810.1K	$17.0M	4.39%	--	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	487.4K	$10.0M	2.64%	+8.3K	2026-06-30
Creative Planning	418.0K	$8.0M	2.26%	+224.8K	2026-06-30
AQR CAPITAL MANAGEMENT LLC	408.1K	$8.0M	2.21%	+111.7K	2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC	363.4K	$7.0M	1.97%	+25.1K	2026-06-30
GEODE CAPITAL MANAGEMENT, LLC	283.2K	$6.0M	1.53%	+18.7K	2026-06-30